Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver structure and function during long-term treatment with cyproterone acetate.

E Kaiser, H S Gruner

    Archives of Gynecology
    |January 1, 1987
    PubMed
    Summary

    Long-term, high-dose cyproterone acetate (CPA) treatment in women did not show adverse effects on liver function or structure. Studies confirmed liver safety in patients undergoing androgenization therapy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Current status and future challenges in implementing and upscaling vertical farming systems.

    Nature food·2023
    Same author

    Sparse identification of nonlinear dynamics for model predictive control in the low-data limit.

    Proceedings. Mathematical, physical, and engineering sciences·2019
    Same author

    Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies.

    Blood cancer journal·2017
    Same author

    [Not Available].

    Arquivos brasileiros de cardiologia·2016
    Same author

    Consumer exposure modelling under REACH: Assessing the defaults.

    Regulatory toxicology and pharmacology : RTP·2015
    Same author

    [Thromboelastometric profile of unwashed shed blood after primary knee arthroplasty].

    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2015

    Area of Science:

    • Endocrinology
    • Hepatology
    • Pharmacology

    Background:

    • Sex steroids, particularly antiandrogens like cyproterone acetate (CPA), are used for long-term treatment of conditions such as androgenization.
    • Concerns exist regarding potential liver toxicity with prolonged, high-dose steroid administration.
    • CPA is a potent antiandrogen and progestogen, necessitating careful evaluation of its hepatic effects.

    Purpose of the Study:

    • To assess the impact of long-term, high-dose cyproterone acetate (CPA) therapy on liver function and structure.
    • To investigate potential liver disturbances in women treated for androgenization using a specific CPA regimen.

    Main Methods:

    • Biochemical liver function tests were conducted.
    • Ultrasonographic examinations of the liver were performed.
    • The study included 77 women with a history of 3 to 11 years of CPA treatment.

    Main Results:

    • No statistically significant disturbances in liver structure were observed via ultrasonography.
    • Biochemical liver function tests did not reveal any adverse effects.
    • The long-term administration of CPA in the studied regimen was found to be safe for the liver.

    Conclusions:

    • Long-term, high-dose cyproterone acetate (CPA) therapy, even for up to 11 years, does not appear to cause liver damage.
    • The reverse sequential treatment scheme with CPA and ethinylestradiol is safe for liver health in women.
    • Clinical observations support the safety profile of CPA in managing androgenization.

    Related Experiment Videos